
Steve Pakola
5 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 5 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $29K | Jul 2SEC filing | |
| Sell | $472K | Jul 1SEC filing | |
| Sell | $216K | Jun 29SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Steve Pakola's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 5 |
Alerts for Steve Pakola
Use this page
How to cite
Breakaway, Steve Pakola: Chief Medical Officer at REGENXBIO (RGNX), Nov 1, 2026, getbreakaway.com/insiders/steve-pakola
Journalists: email support@getbreakaway.com for the data behind this page.